Загрузка...
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
AIMS: The aim of this study was to evaluate the low-density lipoprotein cholesterol lowering efficacy and safety of a bempedoic acid 180 mg and ezetimibe 10 mg fixed-dose combination in patients with hypercholesterolemia and a high risk of cardiovascular disease receiving maximally tolerated statin...
Сохранить в:
| Опубликовано в: : | Eur J Prev Cardiol |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7153222/ https://ncbi.nlm.nih.gov/pubmed/31357887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2047487319864671 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|